CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma

Show other versions (1)

CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC).

Saved in:

Bibliographic Details
Main Authors:	Cai, Xiao Bo (Author) , Yuan, Xiaodong (Author) , Dooley, Steven (Author) , Weng, Honglei (Author)
Format:	Article (Journal)
Language:	English
Published:	06 March 2018
In:	Journal of translational medicine Year: 2018, Volume: 16, Pages: 1-7
ISSN:	1479-5876
DOI:	10.1186/s12967-018-1423-9
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12967-018-1423-9
Author Notes:	Xiaobo Cai, Jun Li, Xiaodong Yuan, Jingbo Xiao, Steven Dooley, Xinjian Wan, Honglei Weng and Lungen Lu

Description
Summary:	CD133 is a marker of stem cells as well cancer stem cells. This study investigated the association between CD133 expression in cancer cells and the clinical outcome of non-mucin producing intrahepatic cholangiocarcinoma (ICC).
Item Description:	Gesehen am 08.06.2020
Physical Description:	Online Resource
ISSN:	1479-5876
DOI:	10.1186/s12967-018-1423-9